Breast and Cervical Cancer Stigma in Rwanda (NCT07663006) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Breast and Cervical Cancer Stigma in Rwanda
Rwanda1,116 participantsStarted 2026-11-01
Plain-language summary
This study aims to assess breast and cervical cancer stigma and pilot a multi-modal intervention to mitigate stigma among patients, caregivers, and community health workers in Rwanda. The elements include resilience training (patient), support group (caregivers), or exposure to survivors by video and in-person (patient, caregivers, and community health workers), and educational curriculum (community health workers).
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Aim 1 Inclusion and Exclusion Criteria Aim 1 Interviews and Surveys
Individual interviews and surveys:
Potential patients will be identified by the clinical team from physical and electronic registries of patients. Potential participants will be screened for eligibility by the study research assistant.
Inclusion Criteria
* Patients with pathologically confirmed breast or cervical cancer
* Patients receiving treatment at BCCOE during the study period
* Age 18 and over
* Ability to provide informed consent
* Ability to participate in interview or surveys in English or Kinyarwanda
Exclusion Criteria
* Unwilling or Unable to consent to participation.
* Unable to comprehend study language (Kinyarwanda or English)
* Individuals who are not yet adults (infants, children, teenagers)
* Prisoners
* Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment
Interpersonal interviews and surveys:
Caregivers of the potential patients will be identified from the potential patients. Potential patients will be identified by the clinical team from physical and electronic registries of patients. Potential participants will be screened for eligibility by the study research assistant.
Inclusion Criteria
* Caregiver (including spouses, children, family members or other individuals as designated by patients) of patients with pathologically confirmed breast or cervical cancer who are actively receiving treatment at BCCOE during the stud…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Prevalence of Cancer Stigma
Timeframe: Baseline
2
Change in Cancer-Related Stigma Score
Timeframe: Baseline and within 4 weeks following completion of the pilot intervention (approximately 4-5 months)
3
Rate of Acceptability of Intervention Components
Timeframe: Within 4 weeks following completion of the intervention delivery period (approximately Month 13)
4
Rate of Appropriateness of Intervention Components
Timeframe: Within 4 weeks following completion of the intervention delivery period (approximately Month 13)
5
Rate of Feasibility of Intervention Components
Timeframe: Within 4 weeks following completion of the intervention delivery period (approximately Month 13)